TrialInfection and immunity2002

A glycoconjugate vaccine for Neisseria meningitidis induces antibodies in human infants that afford protection against meningococcal bacteremia in a neonate rat challenge model.

Kenneth T Mountzouros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.